MomentumOptionsTrading.com Weekly Wrap for 5/15/11
9:15pm (EST)
1. Market Summary
2. MGM Resorts and the Casino Industry – A Winner or a Sucker’s Bet?
3. Amarin (AMRN) – A Winning Pill
4. Earnings
5. Weekly Wrap Portfolio Update
6. Week Ahead
(To view the charts, please log into the Members Area and go to the Weekly Wrap Premium section after 10pm)
= = = = = = = = = = = = = = =
1. Market Summary
The “sell in May and go away” theory has been tested this month but the bulls are doing their best to keep the losses to a minimum. Commodities were a major eyesore for the market as they continued to sell-off but there are pockets of strength that is helping the bulls keep their run intact. We will cover some of the developments we are watching but first let’s look at the numbers.
The Dow fell 100 points on Friday, or 0.8%, to finish at 12,596. The index traded within our trading range we outlined last week although the swings are getting more pronounced. The top of our range has been 12,800 which was tested on Tuesday as the Dow finished at 12,760. However, the bears we able to turn the tables by Wednesday and were taking jabs at our downside target of 12,500. The bulls spent the rest of the week testing 12,750 but eventually lost the battle. For the week, the Dow fell 43 points, or 0.3%. Resistance remains at 12,800 with a possible shot at 13,000 if the blue-chips can clear this level while near-term support lies at 12,500 with 12,350 providing additionally backup.
The S&P 500 dropped 10 points, or 0.8%, on Friday to settle at 1,337. We were looking for a close above 1,334 which marks the double from the March 2009 lows. The bulls were able to push 1,360 early in the week but came nowhere near our 1,375 upside target. To the downside, we have circled 1,325 as a key area to watch along with 1,334 because a breach of these two levels will likely lead to a test of 1,300. The 1,350 level should be watched for a breakout up to 1,370. If cleared, the index could test 1,400, quickly. For the week, the S&P 500 slipped 2 points, or 0.2%.
The Nasdaq held up rather well for the week despite Friday’s 1.2% decline. The index lost nearly 35 points on Friday to finish at 2,828 but was up a point after 5 days of back-and-forth action. We were looking for a push past 2,850 and Tech was able to close above this level on Tuesday and Thursday as it battled 2,875. There is s till a good chance the bulls can hit 3,000 as our downside levels of 2,800-2,750 held all week.
It’s easy to make a case that we are seeing a top but there are some signs that the market can continue to go higher. Although earnings season is winding down, over 70% of companies that have reported thus far have beaten Wall Street’s estimates with quite a few of them actually raising guidance. This is good news for the rest of 2011.
Biotech stocks held up well on Friday and all week. We mentioned a few weeks ago the sector could be a nice place to hang out for a little bit, especially with the 2011 American Society Clinical Oncology (ASCO) Conference coming up this week. This annual meeting is usually a positive catalyst for the sector which features the leading cancer gurus from around the world.
Another point we want to make about the market is this. Bull market rallies show signs of fading with weak Friday and Monday closes. So far for 2011, there have only been three occurrences where the S&P 500 finished lower on a Friday and the Monday after.
The second week of January was the first as the index danced around 1,270 but was looking at 1,250 before breaking 1,300 by month’s end.
The second time we got a lower Friday/ Monday was the first week of March which led to the lows of the month, and, a test of 1,250. After a run towards 1,350 by mid-February, it was only natural for a pullback, which we predicted.
The only other time the S&P has closed lower on a Friday and Monday was in mid-April which is when the 1,300 level was being tested again. Since then, the bulls have built a nice base at 1,325-1,334. However, we knew April was historically a bullish month for the market, averaging 2% gains, so we felt there would be a run back towards 1,350.
We do a lot of chart work, but as you can see, there have been a few simple clues we have been using since LAST October to keep you ahead of the game. Those clues are support and resistance AND the Friday/ Monday sell-off which hasn’t happened. This means money is NOT leaving the market, yet, and we would have to see back-to-back weeks before we see a trend start to change.
We have talked about Ben Bernanke being the centerpiece for a higher market and many on Wall Street see a huge pullback once QE2 (quantitative easing) ends in June. Of course, there has been a lot of talk about a “pullback” but we continue to see higher highs and higher lows for the indexes. Big Ben has said there won’t be a QE3 but we expect a QE2.5 to kick-in if things are still shaky with the economy.
We also want to give you a few thoughts on the S&P 500 Volatility Index (^VIX, 17.07, up 1.04) before we move on. We said that when the bulls reached a peak in April the index could trade down to 13-14 and 14.27 was the low on April 28. The VIX traded up to 20 during the first week of May and is back into the high teens. There is a still a chance the VIX trades back down to 13-14 which would mean Dow 13,000; S&P 1-375-1,400; and Nasdaq 2,900-3,000.
If the VIX pops over 20, then look for our downside targets to be tested.
= = = = = = = = = = = = = = =
2. MGM Resorts and the Casino Industry – A Winner or a Sucker’s Bet?
At the peak of the credit crisis, casino stocks fell to low single digits before making a wild comeback. MGM Resorts International (MGM, $14.72, up $0.31), once the largest casino operator, fell from an October 2007 peak of $96.40 to a March 2009 trough of $1.99. At current prices, MGM has gained of over 700% from the lows.
Below is a list some of the largest publicly trading casinos operators in declining order of market cap, their peak and trough prices around the credit crisis, and their valuations. The red highlighted numbers are the most bearish numbers, while the green ones are the most bullish.
|
G% |
year over year quarterly revenue growth (%) |
P/B |
price/book |
|
tPE |
trailing PE ratio |
PEG |
price/earnings/growth |
|
fPE |
forward PE ratio |
R/S |
revenue/share |
|
P/S |
price/sales |
% |
% short |
|
|
Price |
Peak/Trough |
G% |
tPE |
fPE |
P/S |
P/B |
PEG |
R/S |
% |
|
LVS |
42.60 |
138.25/3.23 |
58.2 |
53.8 |
19.5 |
4.13 |
4.76 |
1.02 |
11.17 |
2.3 |
|
WYNN |
146.27 |
164.65/15.40 |
38.7 |
59.3 |
29.0 |
4.03 |
8.12 |
1.00 |
36.84 |
5.3 |
|
MGM |
14.72 |
96.40/1.99 |
3.3 |
— |
— |
1.16 |
2.41 |
-0.65 |
13.12 |
19 |
|
MPEL |
10.49 |
21.82/2.46 |
93.3 |
— |
38.9 |
2.09 |
2.18 |
0.94 |
4.97 |
6.0 |
|
PENN |
38.85 |
62.25/12.76 |
12.6 |
— |
21.2 |
1.22 |
1.68 |
1.96 |
32.49 |
5.0 |
|
BYD |
10.11 |
56.76/3.10 |
26.4 |
— |
48.1 |
0.39 |
0.74 |
-10.0 |
26.40 |
29 |
|
Industry |
— |
— |
8.6 |
36.0 |
— |
1.18 |
— |
1.00 |
— |
— |
Source: Yahoo Finance
Las Vegas Sands (LVS, $42.60, down $0.79) has overtaken MGM as the world’s largest casino operator by market cap, in large part, because the company was one of the first is Macau, the only location in China where gambling is legal and the fastest growing gambling market in the world. Business there is booming. CLSA Asia Pacific Markets predicts gambling revenue in Macau will grow about 35% to about $32 billion this year. Goldman Sachs predicts that the market will grow to $50 billion by 2013-2015. Last year, gambling revenue soared 58% to $23.5 billion or about four times that of the Las Vegas Strip.
Over 60% of Las Vegas Sands’ total revenue comes from Macau while 18.4% comes from its Marina Bay Sands in Singapore. Sands’ Venetian Macau is the largest casino in the world by floor area and contributes 35.2% of revenue. Sands Macau, which contributes 17.4% of revenue, more than doubled its first-quarter profit. In comparison, Las Vegas only contributes 17.7% to total revenue.
Melco Crown Entertainment’s (MPEL, $10.49, up $0.14) City of Dreams, which sits across the Venetian, reported fourth-quarter year-over-year revenue increase of 100%. Wynn Resorts (WYNN, $146.27, down $0.56), which entered Macau after Sands, said first-quarter profit rose 66%. Revenue at Wynn Macau increased almost 47%, while Las Vegas operations increased by 24%. From that 24%, Vegas casino revenues grew 39% from the first quarter of 2010, and non-casino revenues grew 10.8%.
MGM, however, owns only one casino in Macau, which is actually a joint venture between MGM and the daughter of billionaire Stanley Ho, who owns 20 of the 33 casinos in Macau. The majority of MGM’s properties are in Nevada. The company has about 39% of the gaming market in Vegas and generates slightly less than half of its operating income from casino activities, providing hotels, dining, and entertainment.
Las Vegas Sands looks pricy at 4.13 times sales, but it has the lowest forward PE and short interest, both bullish signs. Melco has the lowest PEG, which is less than one and is selling for less than its expected growth rate. Despite its positive growth, Wynn is near its pre-recession peak and seems pricy based on PE, P/B, and the fact that it is selling for 3.9 times revenue. MGM has the lowest year-over-year quarterly revenue growth and the second highest short interest, both bearish signs but we all know short squeezes can happen.
Both Penn National (PENN, $38.85, down $0.66) and Boyd Gaming (BYD, $10.11, down $0.15) do not have properties in Macau and depend entirely on domestic operations. From the table, Boyd looks cheap selling at less than half revenue and 0.39 times sales. But be careful of the high short interest and negative PEG. Domestic gambling growth is expected to remain sluggish for some time.
After suffering one of the worst downturns in the nation, Las Vegas is slowly coming back. Unemployment at 13% is still one of the highest in the nation, though down from 15%. Additionally, the Las Vegas Convention and Visitors Authority reported that the number of visitors is up 5% so far this year, convention attendance has risen by over 10%, and hotel room rates have increased by nearly 10%.
That said, MGM’s planned $800 million to $1.5 billion June IPO of MGM Macau could boost the company’s books. Similar spin-offs by Las Vegas Sands and Wynn have proved fruitful, as mentioned earlier. MGM Macau will pay a yearly royalty and will likely contribute a similar percentage of revenue. Plus, under the deal, MGM will hold 51% of the company.
Pansy Ho, Stanley Ho’s daughter, will reduce her stake in the company to 29%, leaving the remaining 20% for the open market. But best of all, she agreed to make a $300 million investment in MGM. That is 7% of the float or over 20 million shares. This could easily boost the stock price by $1. Plus, if revenue from its Vegas operations continues to slowly improve, it may do fine.
MGM did report impressive earnings on earlier this month. Below are charts of MGM’s revenue with the August revenue estimate inserted at the end.
As shown in the first graph, the second quarter revenue estimate is about the same growth rate as the previous year. This shouldn’t be hard to meet since conditions are slowly improving in Vegas. The second graph shows that revenue is expected to increase for the second straight quarter.
The chart below gives a bullish breakout picture but bearish technicals. Only one of the three times where the technicals were at similar levels (indicated as vertical purple lines) has the share price gone up afterwards.
Las Vegas Sands and Wynn saw their stock increase 10%-12% in the weeks after issuing their IPOs, so MGM could follow the same path. If we use the current 6 cents a day slope, the stock price would reach $16+ by mid-June and the 52-week high is $16.94. As far as a covered call option trade, the June 11 calls (MGM110618C00016000, $0.60, up $0.15) look interesting if we decide to add MGM to our portfolio this week.
= = = = = = = = = = = = = = =
3. Amarin (AMRN) – A Winning Pill
Amarin (AMRN, $17.00, down $0.24) hit another fresh 52-week high of $17.71 on Friday and has been a hot stock over the past 6 months. The company makes ARM101, a purified fish oil for treating patients with high triglycerides. High triglyceride levels, which affect nearly 40 million people, can cause clogging of blood vessels and cardiovascular disease. Lovaza, marketed by GlaxoSmithKline (GSK, $43.27, up $0.12) and Abbott Laboratories (ABT, $53.49, down $0.04), is a similar drug, also a fish oil, used for lowering cholesterol levels. However, Lovaza does not lower triglyceride levels, but ARM101 does.
A recent report stated that the AMR101 compound succeeded in reducing bad cholesterol. Thus, the drug lowers both bad cholesterol and triglycerides, something Lovaza and other current treatments don’t do. The company plans to submit an application for FDA approval in the third-quarter. There is also the possibility that a larger drug maker may try to buy Amarin before then.
Last week, the company reported a first-quarter loss of 5 cents a share, which was better than analysts’ estimates for a loss of 7 cents. Amarin ended the quarter which $130 million in cash so they have plenty of time to gain approval of the drug without having to raise money or do a secondary offering.
A $25 buyout price would give the company a $2.6 billion market value. ARM101 is estimated to bring in about $1 billion in sales a year. That means that it will take the acquirer 2.6 years to recover the cost if there is a bid of $25, or 50% higher than current levels.
This seems reasonable considering that many blockbuster drugs including Lipitor will go off patent in 2012. Big Pharma may be eager to buy any promising drugs they can find. In comparison, Lipitor had sales of $12.7 billion in 2007. Although $1 billion in sales is not nearly as big as Lipitor sales, it helps, and it is a step.
The graph shows that the sock price is near resistance. Technicals are slightly bullish. The last time three out of the four technicals were at similar levels, the stock rose.
There has been some heavy activity in the call options on shares of Amarin. A recent option buyer purchased a large amount of the June 25 calls (AMRN110618C00025000, $0.25, down $0.05) but this would require a 50% pop from current levels. This is possible, considering the first jump was 50% and the second jump was 100%, but we would use a more conservative 25% jump which gets shares over $20. Therefore, we would target the June 20 calls (AMRN110618C00020000, $1.10, down $0.10) for a continued move higher. This is not an official trade recommendation, just one we will be following over the next few weeks in our Daily publication.
= = = = = = = = = = = = = = =
4. Earnings
The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter. If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week. The first set of companies report before the bell that day, the second set after the market closes. (Quotes are as of Friday’s close, 5/13/11).
MONDAY
China Gengsheng Minerals (CHGS, $2.40, down $0.11), Elbit Systems (ESLT, $51.62, down $0.37), J. C. Penney (JPC, $38.44, down $0.08), Lowe’s (LOW, $25.76, down $0.22), New Energy Systems (NEWN, $2.68, down $0.18), Summit Hotel Properties (INN, $10.65, down $0.63), Urban Outfitters (URBN, $32.62, down $0.37)
Audiovox (VOXX, $7.24, down $0.28), Biostar Pharmaceuticals (BSPM, $1.82, up $0.12), Global Power Equipment Group (GLPW, $29.53, up $0.11), Photronics (PLAB, $8.11, down $0.15), Winn Dixie Stores (WINN, $7.80,down $0.19)
TUESDAY
Dick’s Sporting Goods (DKS, $42.47, down $0.11), Home Depot (HD, $37.01, down $0.28), O’Charley’s (CHUX, $6.62, down $0.42), TJXCompanies (TJX, $54.57, down $0.11), Wal-Mart Stores (WMT, $55.72, flat)
Analog Devices (ADI, $40.79, down $0.68), Dell (DELL, $16.37, down $0.29), Jaguar Mining (JAG, $4.27, down $0.16), Perfect World (PWRD, $24.05, down $0.81), Quantum (QTM, $3.00, down $0.05)
WEDNESDAY
Abercrombie & Fitch (ANF, $74.26, down $0.94), BJ’s Wholesale Club (BJ, $52.00, down $0.18), Chico’s FAS (CHS, $15.29, up $0.11), Deere (DE, $87.72, down $2.64), SodaStream International (SODA, $44.74, down $0.94), Staples (SPLS, $20.25, down $0.15), Target (TGT, $51.52, down $0.24)
Advanced Auto Parts (AAP, $72.16, up $2.75), Hewlett-Packard (HPQ, $40.41, down $0.47), Jack In The Box (JACK, $20.72, down $0.07), Limited brands (LTD, $41.84, down $0.27), Pan American Silver (PAAS, $32.07, down $0.18), Synopsys (SNPS, $27.61, down $0.22)
THURSDAY
Children’s Place Retail Stores (PLCE, $55.35, up $0.65), Dollar Tree (DLTR, $61.03, down $0.49), GameStop (GME, $26.72, up $0.79), PetSmart (PETM, $44.11, down $0.12), Ross Stores (ROST, $82.64, down $0.20), Sears Holding (SHLD, $77.03, down $1.38), The Buckle (BKE, $46.59, up $0.32), Toro (TTC, $64.91, down $0.47), Williams Sonoma (WSM, $44.39, down $0.50)
Aruba Networks (ARUN, $32.24, down $0.25), Autodesk (ADSK, $45.57, down $0.42), Brocade Communications (BRCD, $6.30, down $0.03), Foot Locker (FL, $22.91, up $0.01), Gap (GPS, $23.05, down $0.05) Intuit (INTU, $55.35, down $0.54), Marvell Technology (MRVL, $14.60, down $0.34), Red Robin Gourmet Burgers (RRGB, $28.38, down $0.33), Salesforce.com (CRM, $134.91, down $0.58), Zumiez (ZUMZ, $28.31, down $1.31)
FRIDAY
Ann Taylor Stores (ANN, $31.08, down $0.44), Donaldson Company (DCI, $60.35, down $0.71), E-commerce China Dangdang (DANG, $20.96, down $0.72), Kirklands (KIRK, $15.42, down $0.38), Yingli Green Energy Holding (YGE10.66, down $0.47)
Biglari Holding (BH, $418.19, down $7.02)
= = = = = = = = = = = = = = =
5. Weekly Wrap Covered Call Portfolio Update (Closing prices as of 5/13/11)
Vivus (VVUS, $7.97, down $0.04)
June 8 calls (VVUS110618C00008000, $0.45, down $0.05)
Original Entry Price: $7.93 (5/11/11)
Lowered Price from Selling Options: $7.43
Exit Target: $10+
Return: 7%
Stop Target: None
Action: We want to hold Vivus for the long-term and we realize shares could fade at resistance which is $9 (black line) and was prior short-term support. However, we can continue to sell options month after month while collecting the premium and reducing our cost in the stock. Vivus has the best shot of getting a diet drug on the market in what will easily be a billion dollar-plus field.
We recommended buying the stock at $7.93 on 5/11/11 and for every 100 shares to sell the June 8 calls for 50 cents. This lowered the cost basis to $7.43.
If shares are called away by mid-June at $8 the trades makes 8% in less than 5 weeks.
AKS Steel Holding (AKS, $14.23, down $0.47)
May 16 calls (AKS110521C00016000, $0.03, down $0.03)
Original Entry Price: $15.93 (5/2/11)
Lowered Price from Selling Options: $15.43
Exit Target: $20+
Return: -8%
Stop Target: None
Action: We knew there might be some weakness with AKS Steel because of the commodity selloff last week but we have plenty of time to wait this one out. We like this company as a takeover name and improving fundamentals. Shares are right at their second wave of support (red line) but could be headed into a trading range of $13-$14 if there isn’t a bounce.
We recommended buying the stock at $15.93 on 5/2/11 and for every 100 shares to sell the May 16 calls for 50 cents. This lowered the cost basis to $15.43.
We doubt shares trade back to $16 this week which is when the May options expire. Next week we will look at selling a June or July option to lower our cost basis.
American Capital (ACAS, $10.06, down $0.20)
June 10 calls (ACAS110618C00010000, $0.50, down $0.10)
Original Entry Price: $9.73 (4/19/11)
Lowered Price from Selling Options: $9.23
Exit Target: $15+
Return: 9%
Stop Target: None
Action: American Capital continues to pullback following stellar earnings. Shares appear to be headed back into a trading range of $9.50-$10 and could build a base before its push back towards $10.50.
We recommended buying the stock at $9.73 on 4/19/11 and for every 100 shares to sell the June 10 call for 50 cents. This lowered the cost basis to $9.23.
If shares are called away by mid-June at $10 the trades makes 8%.
Rediff.com India (REDF, $12.50, down $0.45)
May 10 calls (REDF110521C00010000, $2.35, down $0.20)
Original Entry Price: $10.28 (4/19/11)
Lowered Price from Selling Options: $9.03
Exit Target: $15+
Return: 38%
Stop Target: None
Action: Rediff.com was flat for the week which was good considering the week before shares tanked 25%. These options expire this week and shares should be above $10 by Friday. The stock appears like it is trying to build a base at $12 but there is further downside risk if this level is squeezed.
We recommended buying the stock at $10.28 on 4/19/11 and for every 100 shares to sell the May 10 call for $1.25. This lowered the cost basis to $9.03.
If shares are called away on Friday at $10 the trades makes 11%.
Cisco Systems (CSCO, $16.88, down $0.05)
May 18 call (CSCO110521C00018000, $0.02, down $0.01)
Original Entry Price: $17.14 (3/17/11)
Lowered Price from Selling Options: $16.58
Exit Target: $20+
Return: 2%
Stop Target: None
Action: Cisco beat Wall Street’s estimates by 4 cents when they reported last week. Shares traded up over $18, initially, after hearing the news but dropped like a rock when they lowered guidance. Cisco sounded weak on their conference call but vowed to fight back as shares fell back into the trading range we have been outlining since we initiated coverage. This was expected and although it would have been nice to have been called away, we can make a better return if the stock stays in the trading range we have been outlining since we initiated coverage of Cisco.
We recommended buying the stock at $17.14 on 3/17/11 and for every 100 shares to sell the May 18 call for 56 cents. This lowered the cost basis to $16.58.
There was a slight chance we were going to get called away at $18 because shares did pop to $18.50 in after-hours the day the company reported. However, the more their CEO talked, the harder the stock fell. We will look at selling a June or July call option next week.
TiVo (TIVO, $9.41, down $0.01)
May 10 calls (TIVO110521C00009000, $0.09, down $0.02)
Original Entry Price: $8.80 (3/14/11)
Lowered Price from Selling Options: $7.06
Exit Target: $10+
Return: 33%
Stop Target: None
Action: We may or may not get called away on Friday with these May call options but either way, we are on track for solid gains.
If shares are over $10 we will have to close the trade at $10 (even if shares are at $11 or more) as the position will be “called away”. At these levels, the trade will return over 40%. If TiVo is below $10, we can leave the trade open and sell another option or lock in profits.
Shares opened at $8.79 on 3/14/11 and the April calls could have been sold for $1.00. This lowered the cost basis to $7.80. TiVo is a very risky stock to own due to litigation issues but the options have some nice premiums.
On 4/18/11 we suggested selling the May 10 calls for 80-90 cents. The calls opened at 84 cents that day which lowered the cost basis to $7.06.
Spreadtrum Communications (SPRD, $20.64, down $0.52)
May 22.50 calls (SPRD110521C00022500, $0.15, down $0.05)
Entry Price: $23.45 (2/7/11)
Lowered Price from Selling Options: $21.48
Exit Target: $30
Return: -4%
Stop Target: None
Action: Spreadtrum Communications was volatile again last week as it tested support but bounced back hard. We thought there was going to be enough momentum at the beginning of the month to push shares past $22.50 but we aren’t in a hurry to get rid of Spreadtrum any time soon. We will look into selling another call option next week but we want to make sure shares hold $20.
Shares opened at $23.43 on 2/7/11 and the March calls could have been sold for 95 cents. This lowered the cost basis to $22.48.
On 4/11/11 we recommended selling the May 22.50 call option for $1.00 which lowered the cost basis to $21.48.
DryShips (DRYS, $4.40, down $0.28)
January 2012 7.50 call (DRYS120121C00007500, $0.20, flat)
Entry Price: $5.25 (1/03/11)
Lowered Price from Selling Options: $4.60
Exit Target: $8
Return: -4%
Stop Target: None
Action: DryShips announced quarterly earnings last week which doubled last year’s results but shares have trended lower. The stock is on the edge of breaking long-term support (black line) and could test $4 if this level doesn’t hold.
DryShips opened at $5.37 on 1/3/11 and shares were at $5.25 shortly after the bell. The January call options could have been sold for 65 cents which lowered the cost basis to $4.60.
If shares are over $7.50 by January 2012, the stock will be “called away” and the trade will make over 60%.
Seattle Genetics (SGEN, $18.02, up $0.31)
June 17.50 calls (SGEN110618C00017500, $1.20, up $0.35)
Entry Price: $15.50 (12/27/10)
Lowered Price from Selling Options: $13.85
Exit Target: $20
Return: 30%
Stop Target: None
Action: Seattle Genetics added a buck for the week and hit new 52-week highs in the process. We said to watch for the breakout as we now enter blue-sky territory. Since there is no overhead resistance, shares could really start to pick up momentum from here.
We have told you about the company’s drug pipeline which has 2 possible applications currently being looked at by the FDA for approval but there is more to their story. The company also gets licensing fees from other drug makers who use their antibody-drug conjugate (ADC) technology which has brought in more than $145 million so far. We have been saying shares are headed to $20+ in 6-12 months but we might have to lower that outlook to 3-6 months (or weeks). (Note: We also have an ongoing trade in our Daily newsletter for Seattle Genetics).
Seattle Genetics opened at $15.80 and shares were at $15.50 at 10am on 2/27/10. The March 17.50 call option could have been sold for 90 cents. This lowered the cost basis to $14.60.
On 4/4/11, the June calls could have been sold for 75 cents which lowered the cost basis to $13.85. If shares are called away at $17.50 in mid-June the trade will make 26%.
Dendreon (DNDN, $38.03, up $0.23)
May 43 calls (DNDN110521C00043000, $0.08, up $0.03)
Entry Price: $41.96 (9/13/10)
Lowered Price from Selling Options: $36.61
Exit Target: $45
Return: 4%
Stop Target: None
Action: These calls will expire Friday and we will look to sell a June or July option on Dendreon once shares get back over $40. We are looking for the stock to hold a trading range of $38-$42 before the next big pop higher.
Dendreon opened at $41.96 and you could have sold the October 45 call option for $1.30 on 9/13/10. This lowered the cost basis to $40.66.
On 11/11/10 we sold the December 40 call option for $1.75 which lowered our cost basis to $38.91.
On 12/20/10 we sold the February 39 call option for $1.50 which lowered our cost basis to $37.41.
On 4/11/11 we recommended selling the May 43 call options for 80 cents. This lowered the cost basis to $36.61.
= = = = = = = = = = = = = = =
6. Week Ahead
On Monday, the Empire State manufacturing index for May will be released before the bell and usually carries a little weight. Futures could get a bump from any good news or fall further depending on the Monday’s mood on Wall Street. After the bell, the NAHB Housing Market Index is due out.
Tuesday, the market gets an update on Housing Starts and Building Permits along with Industrial Production and Capacity Utilization for April, all before the open.
For Wednesday, we get the regularly scheduled update on domestic petroleum supplies, the MBA Mortgage Index numbers, as well as the latest minutes from the Federal Open Market Committee’s (FOMC) meeting.
The economic calendar wraps up on Thursday with a plenty of news. Before the open, we get the weekly report on jobless claims which include Initial Claims and Continuing Claims. Thirty minutes after the open, the market will get an update on April’s Existing Home Sales along with the latest Philly Fed Index for May.
Although there is no economic news scheduled for Friday, there will be some catalysts that could move the market. May option expiration weeks have been pretty volatile in recent years so this theme will have to be watched all week and on Friday as traders’ battle over key strike prices. Additionally, LinkedIn will back it IPO debut on Thursday or Friday under the ticker symbol “LNKD”.
]]>












